Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alfresa Holdings ( (JP:2784) ) has shared an update.
Alfresa Holdings reported a 5% increase in net sales for the six months ending September 30, 2025, reaching ¥1,529,762 million. Despite the rise in sales, the profit attributable to owners of the parent decreased by 18.1% to ¥11,521 million. The company also revised its forecast for the fiscal year ending March 31, 2026, with expected net sales of ¥3,107,000 million and a significant 31.4% increase in profit attributable to owners of the parent. This financial performance indicates a mixed outlook, with growth in sales but challenges in maintaining profitability, impacting stakeholders’ expectations.
The most recent analyst rating on (JP:2784) stock is a Buy with a Yen2438.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation operates in the healthcare industry, primarily focusing on the distribution of pharmaceuticals and medical devices. The company is listed on the Prime Market of the Tokyo Stock Exchange.
Average Trading Volume: 393,905
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen415.5B
For detailed information about 2784 stock, go to TipRanks’ Stock Analysis page.